Solving tricuspid regurgitation with enabling simplicity.
Discover Tripair™, designed to be a simple, safe and effective tricuspid valve repair solution that breaks barriers to adoption and will provide access to patients beyond the reach of existing therapies.
Coramaze develops Tripair™, a pioneering tricuspid valve repair system designed to overcome the limitations of existing therapies—to make treatment safer, more accessible, and available to a broader patient population.
We aim to improve health equity with a solution that is simple, safe and effective. By overcoming the key challenges of procedural complexity and limited adoption, we are on a mission to make TR treatment as simple as a right heart catheterization — so it can be performed by any interventionalist, anywhere.
designed to be simple. safe. effective.
designed to be simple. safe. effective.
Tripair is designed to be a simple, safe and effective tricuspid valve repair solution that breaks barriers to adoption and that will provide access to patients beyond the reach of existing therapies
Tricuspid Regurgitation (TR) is a dreadful heart valve condition, affecting millions of people. If left untreated, it drastically impacts life expectancy and quality-of-life. Treatment options are limited, and despite its poor prognosis over 90% of patients remain untreated.

Tripair™ intends to create a world with a simple, safe & effective solution to tricuspid regurgitation.
